<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20190415043279N9</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-12-22</date_registration>
      <primary_sponsor>Sanandaj University of Medical Sciences</primary_sponsor>
      <public_title>Evaluation of the effect of Propolis COVID 19</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of the effect of Propolis on the recovery process of COVID 19 patients</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-12-05</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>72</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/52853</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Using block randomization method with a block size of 4. Sampling method at this study will be according to random allocation. Participants will enter the study according to inclusion criteria, and then will be divided into two groups according to randomization table. One group will receive Propolis Capsule and the other will receive placebo. The participants and administrator do not have any information about content of capsules (double blinded study). The list of randomization was computer-generated. supplements and placebo capsules were placed in completely identical packages and were coded by someone who was unaware of the nature of the study in numbered bottles based on the list. And another person who was unaware of the contents of the pack provided them to the patients, Blinding description: All supplements and placebo capsules were identical with respect to appearance and only differed in coding of the capsules. The treatment code of the intervention supplements was blinded for subjects, investigators and staff involved in the conduct of the study.</study_design>
      <phase>3</phase>
      <hc_freetext>Covid-19.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Propolis capsules are taken in the form of 500 mg capsules (made by Shahdineh Golha Company) twice a day for 14 days. Intervention 2: Control group: The placebo is taken as a capsule Twice a day for 14 days.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Vahid Yousefinejad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Kurdistan University of Medical Sciences, Pasdaran Blvd, Sanandaj, Iran</address>
        <city>Sanandaj</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6617713466</zip>
        <telephone>+98 87 3366 4645</telephone>
        <email>hooman56y@yahoo.com</email>
        <affiliation>Sanandaj University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Sabah Hasani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Kurdistan University of Medical Sciences, Pasdaran Blvd</address>
        <city>Sanandaj</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6617713466</zip>
        <telephone>+98 87 3366 4645</telephone>
        <email>S.hasani@muk.ac.ir</email>
        <affiliation>Sanandaj University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Definitive confirmation of Covid 19 based on RT-PCR results
Hospitalized patients
Ventilator independent patients</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Pregnancy
Breastfeeding
Type 1 diabetes
Severe renal failure
Metabolic acidosis
Severe respiratory failure
Chemotherapy recipients
Taking anticoagulants</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>U07.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Other coronavirus as the cause of diseases classified elsewhere</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Placebo</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Propolis capsules are taken in the form of 500 mg capsules (made by Shahdineh Golha Company) twice a day for 14 days.</i_keyword>
      <i_keyword>Control group: The placebo is taken as a capsule Twice a day for 14 days.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Fever. Timepoint: At the beginning of the study (before the intervention), days 3, 5, 7 and after the intervention. Method of measurement: Thermometer.</prim_outcome>
      <prim_outcome>CBC. Timepoint: At the beginning of the study (before the intervention) and after the intervention. Method of measurement: Cell Counter.</prim_outcome>
      <prim_outcome>Cough. Timepoint: At the beginning of the study (before the intervention), days 3, 5, 7 and after the intervention. Method of measurement: Questionnaire.</prim_outcome>
      <prim_outcome>Muscle pain. Timepoint: At the beginning of the study (before the intervention), days 3, 5, 7 and after the intervention. Method of measurement: Questionnaire.</prim_outcome>
      <prim_outcome>C Reactive Protein. Timepoint: At the beginning of the study (before the intervention) and after the intervention. Method of measurement: Agglutination.</prim_outcome>
      <prim_outcome>Blood oxygen saturation percentage. Timepoint: At the beginning of the study (before the intervention), days 3, 5, 7 and after the intervention. Method of measurement: Pulse oximeter.</prim_outcome>
      <prim_outcome>Respiratory Rate. Timepoint: At the beginning of the study (before the intervention), days 3, 5, 7 and after the intervention. Method of measurement: By observing the occurrence of breaths.</prim_outcome>
      <prim_outcome>Heart Rate. Timepoint: At the beginning of the study (before the intervention), days 3, 5, 7 and after the intervention. Method of measurement: Pulse oximeter.</prim_outcome>
      <prim_outcome>Erythrocyte sedimentation rate (ESR). Timepoint: At the beginning of the study (before the intervention) and after the intervention. Method of measurement: ESR device.</prim_outcome>
      <prim_outcome>Lactate Dehydrogenase. Timepoint: At the beginning of the study (before the intervention) and after the intervention. Method of measurement: Autoanalyzer.</prim_outcome>
      <prim_outcome>CT scan findings. Timepoint: At the beginning of the study (before the intervention) and after the intervention. Method of measurement: CT scan.</prim_outcome>
      <prim_outcome>Gastrointestinal symptoms. Timepoint: At the beginning of the study (before the intervention), days 3, 5, 7 and after the intervention. Method of measurement: Questionnaire.</prim_outcome>
      <prim_outcome>Anorexia. Timepoint: At the beginning of the study (before the intervention), days 3, 5, 7 and after the intervention. Method of measurement: Questionnaire.</prim_outcome>
      <prim_outcome>Loss of Smell and Taste. Timepoint: At the beginning of the study (before the intervention), days 3, 5, 7 and after the intervention. Method of measurement: Questionnaire.</prim_outcome>
      <prim_outcome>Shortness of breath. Timepoint: At the beginning of the study (before the intervention), days 3, 5, 7 and after the intervention. Method of measurement: Questionnaire.</prim_outcome>
      <prim_outcome>Headache. Timepoint: At the beginning of the study (before the intervention), days 3, 5, 7 and after the intervention. Method of measurement: Questionnaire.</prim_outcome>
      <prim_outcome>Sore throat. Timepoint: At the beginning of the study (before the intervention), days 3, 5, 7 and after the intervention. Method of measurement: Questionnaire.</prim_outcome>
      <prim_outcome>Body Mass Index (BMI). Timepoint: At the beginning of the study (before the intervention) and after the intervention. Method of measurement: by measuring height and weight using a scale and height meter.</prim_outcome>
      <prim_outcome>IL-6. Timepoint: At the end of the intervention. Method of measurement: ELISA kit.</prim_outcome>
      <prim_outcome>Duration of hospitalization. Timepoint: Daily since hospitalization. Method of measurement: Counting the day.</prim_outcome>
      <prim_outcome>Need for ICU. Timepoint: Daily since hospitalization. Method of measurement: Patient's ﬁle.</prim_outcome>
      <prim_outcome>Need for intubation. Timepoint: Daily since hospitalization. Method of measurement: Patient's ﬁle.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Sanandaj University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-10-13</approval_date>
        <contact_name>Ethics committee of Kurdistan University of Medical Sciences</contact_name>
        <contact_address>Pasdaran Blvd., Kurdistan University of Medical Sciences Sanandaj Kurdistan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
